Frost Radar™: Home-based Ophthalmic Monitoring Solutions, 2020
A Benchmarking System to Spark Companies to Action - Innovation That Fuels New Deal Flow and Growth Pipelines
30-Oct-2020
North America
Frost Radar
D9C4-01-00-00-00
HC03353-NA-TR_24902
$4,950.00
Special Price $3,712.50 save 25 %
Eye diseases such as glaucoma, age-related macular degeneration, diabetic retinopathy, and macular edema require continuous monitoring of eye health, as they can be treated if detected early, but if left undetected, it can silently and rapidly progress to irreversible loss of vision.
Home-based ophthalmic monitoring solutions can help in preventing vision deterioration in patients with high risk of developing debilitating eye conditions by providing timely and early detection of warning signs with continuous monitoring of visual health, and also enabling better ocular disease management by tracking the effectiveness of therapy. Home monitoring solutions provide continuous data on the progress of the disease and also enhance compliance by increasing patient engagement. With the entry of home-based solutions in the ophthalmic space, eye hospitals and ophthalmologists have started adopting innovative business models. It is creating a transformative mega trend in the ophthalmology practice.
Strategic Imperative
Strategic Imperative (continued)
Growth Environment
Frost Radar™: Home-based Ophthalmic Monitoring Solutions
Frost Radar™
Frost Radar™
Notal Vision
EyeQue Corporation
Implandata Ophthalmic Products
Revenio Group
SENSIMED
Oculocare Medical
Genentech
GLANCE Optical Pty. Ltd.
EyeLab Ltd.
Kubota Vision
Injectsense
Qura
Strategic Insights
Significance of Being on the Frost Radar™
Frost Radar™ Empowers the CEO’s Growth Team
Frost Radar™ Empowers Investors
Frost Radar™ Empowers Customers
Frost Radar™ Empowers the Board of Directors
Frost Radar™: Benchmarking Future Growth Potential
Frost Radar™: Benchmarking Future Growth Potential
Legal Disclaimer
Frost Radar™: Benchmarking Future Growth Potential 2 Major Indices, 10 Analytical Ingredients, 1 Platform
Growth Index
Growth Index (GI) is a measure of a company’s growth performance and track record, along with its ability to develop and execute a fully aligned growth strategy and vision; a robust growth pipeline system; and effective market, competitor, and end-user focused sales and marketing strategies.
-
Market Share (previous 3 years)
This is a comparison of a company’s market share relative to its competitors in a given market space for the previous 3 years. -
Revenue Growth (previous 3 years)
This is a look at a company’s revenue growth rate for the previous 3 years in the market/industry/category that forms the context for the given Frost Radar™. -
Growth Pipeline
This is an evaluation of the strength and leverage of a company’s growth pipeline system to continuously capture, analyze, and prioritize its universe of growth opportunities. -
Vision and Strategy
This is an assessment of how well a company’s growth strategy is aligned with its vision. Are the investments that a company is making in new products and markets consistent with the stated vision? -
Sales and Marketing
This is a measure of the effectiveness of a company’s sales and marketing efforts in helping it drive demand and achieve its growth objectives.
Innovation Index
Innovation Index (II) is a measure of a company’s ability to develop products/ services/ solutions (with a clear understanding of disruptive Mega Trends) that are globally applicable, are able to evolve and expand to serve multiple markets and are aligned to customers’ changing needs.
-
INNOVATION SCALABILITY
This determines whether an organization’s innovations are globally scalable and applicable in both developing and mature markets, and also in adjacent and non-adjacent industry verticals. -
RESEARCH AND DEVELOPMENT
This is a measure of the efficacy of a company’s R&D strategy, as determined by the size of its R&D investment and how it feeds the innovation pipeline. -
PRODUCT PORTFOLIO
This is a measure of a company’s product portfolio, focusing on the relative contribution of new products to its annual revenue. -
MEGATRENDS LEVERAGE
This is an assessment of a company’s proactive leverage of evolving, long-term opportunities and new business models, as the foundation of its innovation pipeline. -
CUSTOMER ALIGNMENT
This evaluates the applicability of a company’s products/services/solutions to current and potential customers, as well as how its innovation strategy is influenced by evolving customer needs.
Significance of Being on the Frost Radar™
Companies plotted on the Frost RadarTM are the leaders in the industry for growth, innovation, or both. They are instrumental in advancing the industry into the future.
-
GROWTH POTENTIAL
Your organization has significant future growth potential, which makes it a Company to Action. -
BEST PRACTICES
Your organization is well positioned to shape Growth Pipeline™ best practices in your industry. -
COMPETITIVE INTENSITY
Your organization is one of the key drivers of competitive intensity in the growth environment. -
CUSTOMER VALUE
Your organization has demonstrated the ability to significantly enhance its customer value proposition. -
PARTNER POTENTIAL
Your organization is top of mind for customers, investors, value chain partners, and future talent as a significant value provider.
Speak directly with our analytics experts for tailored recommendations.
Recent related Healthcare research
04 Aug 2026 | Global | Market Research
Global Capnography Devices Market, Forecast to 2031
The capnography market is undergoing a significant transformation from its traditional role in anesthesia and intensive care monitoring to a broader, continuous respiratory surveillance ecosystem. This evolution is being driven by increasing integration of capnography into multiparameter monitoring ...
31 Jul 2026 | Global | Market Research
Growth Opportunities in Small-Molecule Contract Development and Manufacturing Organizations, Global, 2026–2031
The global small‑molecule CDMO industry is undergoing a structural transformation driven by increasing molecular complexity, patent expiries, cost pressures, and the strategic need to secure resilient pharmaceutical supply chains. Demand is shifting beyond high‑volume commodity generics toward s...
30 Jul 2026 | Global | Frost Radar
Frost Radar™: Life Sciences Regulatory Information Management Platforms, 2026
The regulatory technology market in life sciences has, over the last five years, quietly transformed from a back-office category dominated by document repositories and submission publishing tools to one of the most consequential software segments serving the pharmaceutical, biotech, and medical devi...
30 Jul 2026 | Global | Technology Research
Innovations and Growth Opportunities in Advanced Medical Devices, Artificial Intelligence Solutions, Wearables and Drug Delivery Solutions
The latest issue of Advanced MedTech Technology Opportunity Engine (TOE) spotlights a diverse slate of innovations across advanced medical devices, artificial intelligence solutions, wearables and drug delivery solutions.
The issue features advanced medical devices such as non-invasive bimoda...
24 Jul 2026 | Global | Frost Radar
Frost Radar™: Neuromodulation Devices, 2026
Neuromodulation is increasingly recognized as an effective method for managing chronic conditions and improving patients’ quality of life, gaining momentum as a cost-efficient, long-term treatment for neurological and nerve-related disorders. The prevalence of neurological disorders and nerve inju...
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.
| Deliverable Type | Frost Radar |
|---|---|
| No Index | No |
| Podcast | No |
| Author | Sneha Maria Mariawilliam |
| Industries | Healthcare |
| WIP Number | D9C4-01-00-00-00 |
| Is Prebook | No |